Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CBT | Common Stock | Options Exercise | $609K | +14.9K | +24.09% | $40.97 | 76.6K | Aug 19, 2024 | Direct | |
transaction | CBT | Common Stock | Sale | -$1.5M | -14.9K | -19.42% | $100.91 | 61.7K | Aug 19, 2024 | Direct | F1 |
transaction | CBT | Common Stock | Options Exercise | $179K | +4.38K | +7.1% | $40.97 | 66.1K | Aug 20, 2024 | Direct | |
transaction | CBT | Common Stock | Sale | -$442K | -4.38K | -6.63% | $100.93 | 61.7K | Aug 20, 2024 | Direct | F2 |
transaction | CBT | Common Stock | Options Exercise | $44.2K | +1.08K | +1.75% | $40.97 | 62.8K | Aug 20, 2024 | Direct | |
transaction | CBT | Common Stock | Sale | -$107K | -1.08K | -1.72% | $99.16 | 61.7K | Aug 20, 2024 | Direct | |
holding | CBT | Common Stock | 7.12K | Aug 19, 2024 | Through the Trustee for the Corporation's 401(k) Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CBT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -14.9K | -73.14% | $0.00 | 5.46K | Aug 19, 2024 | Common Stock | 14.9K | $40.97 | Direct | F3 |
transaction | CBT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -4.38K | -80.25% | $0.00 | 1.08K | Aug 20, 2024 | Common Stock | 4.38K | $40.97 | Direct | F3 |
transaction | CBT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -1.08K | -100% | $0.00 | 0 | Aug 20, 2024 | Common Stock | 1.08K | $40.97 | Direct | F3 |
Id | Content |
---|---|
F1 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.900 to $100.985, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
F2 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.900 to $101.000, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
F3 | 32,507 shares were subject to the option. The option vested over a three year period as follows: 30% on November 13, 2021, 30% on November 13, 2022 and 40% on November 13, 2023. |